title: Developing a public health research agenda for women with blood disorders.
abstract: Bleeding and clotting in women is an issue that directly affects the life of every woman, child, and family worldwide. This article summarizes recent activities undertaken by the Division of Blood Disorders (DBD) at the Centers for Disease Control and Prevention (CDC) to identify risk factors through evidence-based research and surveillance to prevent complications of blood disorders in women. Specific focus is given to our efforts to improve early identification and diagnosis of blood disorders among women, improve our understanding of maternal and infant outcomes, and develop surveillance systems to monitor the prevalence and incidence of these events.
authors.affiliation: Division of Blood Disorders, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. vbyams@cdc.gov
authors.forename: Vanessa R
authors.initials: VR
authors.lastname: Byams
authors.forename: Michele G
authors.initials: MG
authors.lastname: Beckman
authors.forename: Althea M
authors.initials: AM
authors.lastname: Grant
authors.forename: Christopher S
authors.initials: CS
authors.lastname: Parker
mesh_terms: D002487:Centers for Disease Control and Prevention, U.S.; D019317:Evidence-Based Medicine; D005260:Female; D006302:Health Services Research; D006402:Hematologic Diseases / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D011159:Population Surveillance; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D011256:Pregnancy Outcome; D012307:Risk Factors; D014481:United States